Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins (Subcutaneous Syringes; V01Aa02, V01Aa03, V01Aa05), For The Period 01.11.2024 - 31.10.2026

DAK-Gesundheit Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins (Subcutaneous Syringes; V01Aa02, V01Aa03, V01Aa05), For The Period 01.11.2024 - 31.10.2026 in Pharmaceuticals. The tender was released on Sep 17, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins (Subcutaneous Syringes; V01Aa02, V01Aa03, V01Aa05), For The Period 01.11.2024 - 31.10.2026

Deadline - Sep 05, 2026

MT reference number - 93381416

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 93381416

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for medicines dispensed at the expense of statutory health insurance companies. In view of the relev ant statutory provisions for the award of public contracts, DAK-Gesundheit carries out a regular process of active ingredient-related, formal tendering procedures in accordance with the provisions of Part 4 of the GWB. For medicines with the above-mentioned active ingredient, allergen extract of various origins (exclusively injection suspension for subcutaneous use), ATC V01AA02, V01AA03, V01AA05, which are to be specified by the bidder in Annex

Mt Ref Id - 93381416

Deadline - Sep 05, 2026

Share

Similar Tenders :